Histone deacetylase 6 delays motor neuron degeneration by ameliorating the autophagic flux defect in a transgenic mouse model of amyotrophic lateral sclerosis - PubMed (original) (raw)
Histone deacetylase 6 delays motor neuron degeneration by ameliorating the autophagic flux defect in a transgenic mouse model of amyotrophic lateral sclerosis
Sheng Chen et al. Neurosci Bull. 2015 Aug.
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the selective loss of motor neurons. Abnormal protein aggregation and impaired protein degradation are believed to contribute to the pathogenesis of this disease. Our previous studies showed that an autophagic flux defect is involved in motor neuron degeneration in the SOD1(G93A) mouse model of ALS. Histone deacetylase 6 (HDAC6) is a class II deacetylase that promotes autophagy by inducing the fusion of autophagosomes to lysosomes. In the present study, we showed that HDAC6 expression was decreased at the onset of disease and became extremely low at the late stage in ALS mice. Using lentivirus-HDAC6 gene injection, we found that HDAC6 overexpression prolonged the lifespan and delayed the motor neuron degeneration in ALS mice. Moreover, HDAC6 induced the formation of autolysosomes and accelerated the degradation of SOD1 protein aggregates in the motor neurons of ALS mice. Collectively, our results indicate that HDAC6 has neuroprotective effects in an animal model of ALS by improving the autophagic flux in motor neurons, and autophagosome-lysosome fusion might be a therapeutic target for ALS.
Similar articles
- MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis.
Zhang X, Chen S, Song L, Tang Y, Shen Y, Jia L, Le W. Zhang X, et al. Autophagy. 2014 Apr;10(4):588-602. doi: 10.4161/auto.27710. Epub 2014 Jan 15. Autophagy. 2014. PMID: 24441414 Free PMC article. - Distinct roles for motor neuron autophagy early and late in the SOD1G93A mouse model of ALS.
Rudnick ND, Griffey CJ, Guarnieri P, Gerbino V, Wang X, Piersaint JA, Tapia JC, Rich MM, Maniatis T. Rudnick ND, et al. Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):E8294-E8303. doi: 10.1073/pnas.1704294114. Epub 2017 Sep 13. Proc Natl Acad Sci U S A. 2017. PMID: 28904095 Free PMC article. - Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Zhang X, Li L, Chen S, Yang D, Wang Y, Zhang X, Wang Z, Le W. Zhang X, et al. Autophagy. 2011 Apr;7(4):412-25. doi: 10.4161/auto.7.4.14541. Epub 2011 Apr 1. Autophagy. 2011. PMID: 21193837 - Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
Tu PH, Gurney ME, Julien JP, Lee VM, Trojanowski JQ. Tu PH, et al. Lab Invest. 1997 Apr;76(4):441-56. Lab Invest. 1997. PMID: 9111507 Review. - Therapeutic targeting of epigenetic components in amyotrophic lateral sclerosis (ALS).
Lee J, Ryu H, Keum G, Yoon YJ, Kowall NW, Ryu H. Lee J, et al. Curr Med Chem. 2014;21(31):3576-82. doi: 10.2174/0929867321666140706131825. Curr Med Chem. 2014. PMID: 25005187 Review.
Cited by
- A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed?
Xu X, Shen D, Gao Y, Zhou Q, Ni Y, Meng H, Shi H, Le W, Chen S, Chen S. Xu X, et al. Transl Neurodegener. 2021 Aug 10;10(1):29. doi: 10.1186/s40035-021-00250-5. Transl Neurodegener. 2021. PMID: 34372914 Free PMC article. Review. - Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis.
Klingl YE, Pakravan D, Van Den Bosch L. Klingl YE, et al. Br J Pharmacol. 2021 Mar;178(6):1353-1372. doi: 10.1111/bph.15217. Epub 2020 Aug 26. Br J Pharmacol. 2021. PMID: 32726472 Free PMC article. Review. - Clinical validation of the novel HDAC6 radiotracer [18F]EKZ-001 in the human brain.
Koole M, Van Weehaeghe D, Serdons K, Herbots M, Cawthorne C, Celen S, Schroeder FA, Hooker JM, Bormans G, de Hoon J, Kranz JE, Van Laere K, Gilbert TM. Koole M, et al. Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):596-611. doi: 10.1007/s00259-020-04891-y. Epub 2020 Jul 8. Eur J Nucl Med Mol Imaging. 2021. PMID: 32638097 Free PMC article. - Mitochondrial Dysfunction, Neurogenesis, and Epigenetics: Putative Implications for Amyotrophic Lateral Sclerosis Neurodegeneration and Treatment.
Calió ML, Henriques E, Siena A, Bertoncini CRA, Gil-Mohapel J, Rosenstock TR. Calió ML, et al. Front Neurosci. 2020 Jul 15;14:679. doi: 10.3389/fnins.2020.00679. eCollection 2020. Front Neurosci. 2020. PMID: 32760239 Free PMC article. Review. - Screens in aging-relevant human ALS-motor neurons identify MAP4Ks as therapeutic targets for the disease.
Liu ML, Ma S, Tai W, Zhong X, Ni H, Zou Y, Wang J, Zhang CL. Liu ML, et al. Cell Death Dis. 2024 Jan 4;15(1):4. doi: 10.1038/s41419-023-06395-7. Cell Death Dis. 2024. PMID: 38177100 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous